2024 annual financial data
Intellia Therapeutics 2024 Operating margin
Intellia Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -923.1%.
Operating income was -534,263,000 USD and net income was -519,021,000 USD.
Operating cash flow was -348,880,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,877,000 USD
- Operating income
- -534,263,000 USD
- Net income
- -519,021,000 USD
- Operating cash flow
- -348,880,000 USD